Fatigue

WEST PALM BEACH, Fla. — The “wearing-off” effect with monoclonal antibodies prescribed for multiple sclerosis led to treatment dissatisfaction and was associated with depression, according to a poster from ACTRIMS 2024.

In this Healio video, Philip J. Mease, MD, discusses ongoing clinical trials in psoriatic arthritis and data presented at ACR Convergence 2023, as well as upcoming research.

Treatment with apitegromab was linked to improved muscle strength and range of motion, while being safe and well-tolerated in those with spinal muscular atrophy types 2 and 3, according to a poster presentation.

Fatigue among patients with psoriasis with or without psoriatic arthritis was associated with joint paint, itch and, to a lesser extent, disease severity, according to a study.

WEST PALM BEACH, Fla. — Oral administration of vidofludimus calcium reduced fatigue over 14 days compared with placebo and may have a long-term positive effect in multiple sclerosis, according to a poster presented at ACTRIMS 2024.

SCOTTSDALE, Ariz. — Long COVID, fibromyalgia and chronic fatigue syndrome demonstrate overlapping characteristics that warrant further investigation, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.

A new at-home menopause test hit the market last fall, promising women the ability to accurately measure a hormone associated with menopause stage and predict how close they might be to their final menstrual period.

In this video exclusive, Nicole Gomez, MD, talks with Caroline T. Nguyen, MD, about diagnosing and managing thyroid dysfunction in the postpartum period.

COVID-19 may quadruple a person’s risk for chronic fatigue, new study findings suggest.

Among patients with progressive pulmonary fibrosis, taking nintedanib for 52 weeks lowered the degree of worsened dyspnea, fatigue and cough compared with placebo, according to results published in European Respiratory Journal.